Dynamics of reverse cholesterol transport: protection against atherosclerosis (Q34558799)

3 August 2017

1 reference

title

Dynamics of reverse cholesterol transport: protection against atherosclerosis (English)

1 reference

3 August 2017

1 reference

Dmitri Sviridov

1

1 reference

PubMed ID

11888506

3 August 2017

Paul Nestel

series ordinal

2

1 reference

3 August 2017

1 April 2002

1 reference

3 August 2017

1 reference

3 August 2017

161

1 reference

3 August 2017

2

1 reference

3 August 2017

245-254

1 reference

High density lipoprotein cholesterol and mortality. The Framingham Heart Study

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

High-density lipoprotein--the clinical implications of recent studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Identification of a sequence of apolipoprotein A-I associated with the activation of Lecithin:Cholesterol acyltransferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Plasma lipid transfer proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Lipoproteins of human peripheral lymph

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Centripetal cholesterol flux from extrahepatic organs to the liver is independent of the concentration of high density lipoprotein-cholesterol in plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

High levels of human apolipoprotein A-I and high density lipoproteins in transgenic mice do not enhance efflux of cholesterol from a depot of injected lipoproteins. Relevance to regression of atherosclerosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Lack of apoA-I is not associated with increased susceptibility to atherosclerosis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

HDL deficiency in genetically engineered mice requires elevated LDL to accelerate atherogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Characterization of atherosclerosis in a patient with familial high-density lipoprotein deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Familial HDL deficiency due to marked hypercatabolism of normal apoA-I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Severe familial HDL deficiency in French-Canadian kindreds. Clinical, biochemical, and molecular characterization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

A novel mutant, ApoA-I nichinan (Glu235-->0), is associated with low HDL cholesterol levels and decreased cholesterol efflux from cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Prevention of coronary heart disease by raising high-density lipoprotein cholesterol?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Elevated HDL cholesterol is a risk factor for ischemic heart disease in white women when caused by a common mutation in the cholesteryl ester transfer protein gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality. A 21-year follow-up of 8000 men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Antioxidative activity of high density lipoproteins in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Oxidation of high density lipoproteins. I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that accompanies lipid peroxidation and can be enhanced by alpha-tocopherol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

HDL3-mediated inhibition of thrombin-induced platelet aggregation and fibrinogen binding occurs via decreased production of phosphoinositide-derived second messengers 1,2-diacylglycerol and inositol 1,4,5-tris-phosphate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Phosphoproteins regulated by the interaction of high-density lipoprotein with human skin fibroblasts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Induction of cellular cholesterol efflux to lipid-free apolipoprotein A-I by cAMP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Associations of the HDL2 and HDL3 cholesterol subfractions with the development of ischemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Associations of HDL2 and HDL3 subfractions with ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Differential role of apolipoprotein AI-containing particles in cholesterol efflux from adipose cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Modulation of cholesterol efflux from Fu5AH hepatoma cells by the apolipoprotein content of high density lipoprotein particles. Particles containing various proportions of apolipoproteins A-I and A-II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Cholesterol Efflux, Lecithin−Cholesterol Acyltransferase Activity, and Pre-β Particle Formation by Serum from Human Apolipoprotein A-I and Apolipoprotein A-I/Apolipoprotein A-II Transgenic Mice Consistent with the Latter Being Less Effective for R

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Cholesterol efflux, cholesterol esterification, and cholesteryl ester transfer by LpA-I and LpA-I/A-II in native plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Selective uptake of cholesteryl esters from high-density lipoprotein-derived LpA-I and LpA-I:A-II particles by hepatic cells in culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Cholesterol efflux from human monocyte-derived macrophages in the presence of LpA-I:A-II

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Turnover of plasma esterified cholesterol in normocholesterolemic and hypercholesterolemic subjects and its relation to body build

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Quantitation of pre beta-HDL-dependent and nonspecific components of the total efflux of cellular cholesterol and phospholipid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apo A-I-containing subpopulations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Presence and formation of 'free apolipoprotein A-I-like' particles in human plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Role of free apolipoprotein A-I in cholesterol efflux. Formation of pre-alpha-migrating high-density lipoprotein particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Cycling of apolipoprotein A-I between lipid-associated and lipid-free pools

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Apolipoprotein-mediated cellular cholesterol/phospholipid efflux and plasma high density lipoprotein level in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

The correlation of ATP-binding cassette 1 mRNA levels with cholesterol efflux from various cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Age and residual cholesterol efflux affect HDL cholesterol levels and coronary artery disease in ABCA1 heterozygotes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Lecithin:cholesterol acyltransferase overexpression generates hyperalpha-lipoproteinemia and a nonatherogenic lipoprotein pattern in transgenic rabbits.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

High plasma HDL concentrations associated with enhanced atherosclerosis in transgenic mice overexpressing lecithin-cholesteryl acyltransferase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Cholesteryl ester transfer protein corrects dysfunctional high density lipoproteins and reduces aortic atherosclerosis in lecithin cholesterol acyltransferase transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Association of cholesteryl ester transfer protein-TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the Framingham study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Common cholesteryl ester transfer protein mutations, decreased HDL cholesterol, and possible decreased risk of ischemic heart disease: The Copenhagen City Heart Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Hepatic lipase deficiency increases plasma cholesterol but reduces susceptibility to atherosclerosis in apolipoprotein E-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Hepatic lipase deficiency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Hyperalphalipoproteinemia: characterization of a cardioprotective profile associating increased high-density lipoprotein2 levels and decreased hepatic lipase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Identification of scavenger receptor SR-BI as a high density lipoprotein receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Cubilin, the endocytic receptor for intrinsic factor-vitamin B(12) complex, mediates high-density lipoprotein holoparticle endocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Megalin acts in concert with cubilin to mediate endocytosis of high density lipoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

The intrinsic factor-vitamin B12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Relationship between expression levels and atherogenesis in scavenger receptor class B, type I transgenics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Defective forebrain development in mice lacking gp330/megalin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Stimulation of fecal steroid excretion after infusion of recombinant proapolipoprotein A-I. Potential reverse cholesterol transport in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Depletion of pre beta 1LpA1 and LpA4 particles by mast cell chymase reduces cholesterol efflux from macrophage foam cells induced by plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

High prebeta1-HDL levels in hypercholesterolemia are maintained by probucol but reduced by a low-cholesterol diet.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Prebeta1-high-density lipoprotein (prebeta1-HDL) concentration can change with low-density lipoprotein-cholesterol (LDL-C) concentration independent of cholesteryl ester transfer protein (CETP)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Effect of weight reduction on the distribution of apolipoprotein A-I in high-density lipoprotein subfractions in obese non-insulin-dependent diabetic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Bezafibrate increases prebeta 1-HDL at the expense of HDL2b in hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

ABCA1 is the cAMP-inducible apolipoprotein receptor that mediates cholesterol secretion from macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Familial HDL deficiency characterized by hypercatabolism of mature apoA-I but not proapoA-I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Increased plasma cholesteryl ester transfer protein in obese subjects. A possible mechanism for the reduction of serum HDL cholesterol levels in obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Effect of adiposity on plasma lipid transfer protein activities: a possible link between insulin resistance and high density lipoprotein metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Plasma lipoprotein distribution and lipid transfer activities in patients with type IIb hyperlipidemia treated with simvastatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

Cholesterol Metabolism in Human Obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2801%2900677-3

10.1016/S0021-9150(01)00677-3

7 January 2021

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

11888506